PAVmed (PAVM) Earnings Analysis

PAVmed (PAVM) next reports earnings on 2026-08-13, consensus EPS -0.63 USD. Last quarter (2026-05-15) it missed with EPS -4.42 USD vs -0.69 USD est (-540.6%). It has beaten estimates in 4/6 recent quarters (67%). Trailing P/E -0.13.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does PAVM next report earnings?

Next earnings date2026-08-13
Consensus EPS estimate-0.63 USD
Revenue estimate0.00B

PAVM earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-05-15-4.42 USD-0.69 USD-540.6%Miss
2026-03-26-2.05 USD-4.5 USD+54.4%Beat
2025-11-13-8.41 USD-6.01 USD-39.9%Miss
2025-08-14-0.05 USD-0.25 USD+80%Beat
2025-05-15-0.07 USD-0.29 USD+75.9%Beat
2024-11-13-0.54 USD-1.3 USD+58.5%Beat

Beat rate: 4/6 (67%) over reported quarters with consensus data.

PAVM valuation and analyst view

Trailing P/E-0.13
Trailing EPS-11.78336 USD
Price / book0.19
Dividend yield0.00%
Market cap0.00B
Analyst consensusBuy (2 buy / 1 hold / 0 sell)

Related research pages

Frequently asked questions

When is PAVmed (PAVM)'s next earnings date?

PAVmed is next scheduled to report on 2026-08-13, with a consensus EPS estimate of -0.63 USD and revenue estimate of 0.00B.

Did PAVM beat earnings last quarter?

In its 2026-05-15 report, PAVM posted EPS of -4.42 USD versus a -0.69 USD estimate — a miss of 540.6%.

What is PAVM's earnings track record?

Over the last 6 reported quarters with consensus data, PAVM beat estimates 4 times (67%).

What is PAVM's current P/E ratio and EPS?

PAVM trades at a trailing P/E of -0.13 on trailing EPS of -11.783363740109364 USD.

What do analysts rate PAVM?

Analyst consensus is "Buy" across 3 ratings (0 strong buy, 2 buy, 1 hold, 0 sell, 0 strong sell).